We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current HRGN market cap is 46.48M. The company's latest EPS is USD -0.5667 and P/E is -5.15.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 103k |
| Operating Income | -8.87M | -5.33M | -8.64M | -6.15M | -8.99M |
| Net Income | -8.33M | -4.87M | -7.98M | -6.25M | -9.02M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.99M | 2.08M | 1.87M | 2.4M | 2.61M |
| Total Liabilities | 903k | 951k | 4.9M | 1.41M | 968k |
| Total Equity | 1.09M | 1.13M | -3.03M | -3.19M | 1.65M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.06M | -4.04M | -2.63M | -5.11M | -6.94M |
| Investing | -129k | -7k | N/A | -5k | -11k |
| Financing | 5.8M | 4.16M | 2.84M | 5.06M | 6.14M |
| Market Cap | 46.48M |
| Price to Earnings Ratio | -5.15 |
| Price to Sales Ratio | 449.23 |
| Price to Cash Ratio | 107.75 |
| Price to Book Ratio | 28.24 |
| Dividend Yield | - |
| Shares Outstanding | 15.92M |
| Average Volume (1 week) | 764 |
| Average Volume (1 Month) | 1.11k |
| 52 Week Change | -24.16% |
| 52 Week High | 5.90 |
| 52 Week Low | 2.13 |
| Spread (Intraday) | 0.12 (4.04%) |
| Company Name | Harvard Apparatus Regenerative Technology Inc (QB) |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://hregen.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
